CA2517572C — Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
Assigned to Merck Sharp and Dohme LLC · Expires 2011-12-13 · 14y expired
What this patent protects
The present invention provides substituted azetidinone compounds of formula (I), formulations and processes for preparing the same which can be useful for treating vascular conditions such as atherosclerosis or hypercholesterolemia, diabetes, obesity, stroke, demyelination and lo…
USPTO Abstract
The present invention provides substituted azetidinone compounds of formula (I), formulations and processes for preparing the same which can be useful for treating vascular conditions such as atherosclerosis or hypercholesterolemia, diabetes, obesity, stroke, demyelination and lowering plasma levels of sterols and/or stanols in a subject.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.